Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (323)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
83
2025
3013
9.540
Why?
Antibodies, Bispecific
13
2025
104
4.140
Why?
B-Cell Maturation Antigen
9
2025
95
2.430
Why?
Immunotherapy, Adoptive
7
2025
156
1.940
Why?
Hematopoietic Stem Cell Transplantation
8
2024
600
1.880
Why?
Humans
99
2026
52441
1.290
Why?
Neoplasm, Residual
7
2025
169
1.290
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
123
1.290
Why?
Leukemia, Plasma Cell
2
2020
33
1.260
Why?
Neoplasms, Plasma Cell
3
2024
35
1.230
Why?
Paraproteinemias
2
2022
72
1.210
Why?
Positron-Emission Tomography
5
2025
297
1.160
Why?
Neoplasm Recurrence, Local
10
2025
639
1.140
Why?
Bone Marrow
10
2022
354
1.120
Why?
Myelodysplastic Syndromes
6
2026
86
1.080
Why?
Diffusion Magnetic Resonance Imaging
3
2025
131
1.050
Why?
Aged
32
2025
10242
1.050
Why?
Immunoglobulin Light Chains
2
2017
90
0.960
Why?
Prognosis
18
2025
2100
0.910
Why?
Transplantation, Autologous
9
2024
479
0.900
Why?
Middle Aged
31
2025
13133
0.880
Why?
Gene Expression Regulation, Neoplastic
10
2024
853
0.880
Why?
Immunoglobulins, Intravenous
1
2025
63
0.880
Why?
Immunoconjugates
2
2022
37
0.830
Why?
Mutation
8
2022
1331
0.830
Why?
Male
39
2025
26874
0.790
Why?
Adult
27
2025
14205
0.770
Why?
Antibodies, Monoclonal
6
2023
475
0.770
Why?
Leukemia, Myeloid, Acute
4
2019
202
0.730
Why?
Gene Expression Profiling
11
2025
1099
0.730
Why?
Health Personnel
1
2024
255
0.710
Why?
Aged, 80 and over
13
2025
3449
0.680
Why?
Signal Transduction
6
2024
1724
0.660
Why?
Testis
1
2021
74
0.660
Why?
Female
35
2025
28277
0.640
Why?
Tumor Microenvironment
5
2024
257
0.640
Why?
Hematopoietic Stem Cells
3
2019
180
0.630
Why?
Plasma Cells
6
2025
233
0.620
Why?
Cell Proliferation
8
2023
1013
0.610
Why?
Quality of Life
1
2025
893
0.610
Why?
Gene Expression
3
2018
618
0.590
Why?
DNA Methylation
5
2026
573
0.550
Why?
Clinical Trials as Topic
6
2023
461
0.540
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1020
0.540
Why?
Translocation, Genetic
5
2021
266
0.520
Why?
Thoracic Neoplasms
1
2016
13
0.490
Why?
Plasmacytoma
1
2016
44
0.470
Why?
Receptors, Interleukin-8B
1
2015
5
0.460
Why?
Survival Analysis
8
2024
656
0.460
Why?
Interleukin-8
1
2015
86
0.450
Why?
Recurrence
7
2025
680
0.410
Why?
Receptors, G-Protein-Coupled
2
2024
57
0.410
Why?
Antineoplastic Agents
7
2024
1216
0.400
Why?
Clonal Evolution
3
2021
57
0.390
Why?
Combined Modality Therapy
4
2024
641
0.390
Why?
Drug Resistance, Neoplasm
2
2026
336
0.380
Why?
Fluorodeoxyglucose F18
5
2021
181
0.380
Why?
Neutropenia
2
2023
113
0.370
Why?
Neoplasms, Second Primary
2
2024
75
0.360
Why?
Cell Line, Tumor
8
2026
1429
0.360
Why?
Oncogene Proteins, Fusion
2
2018
61
0.360
Why?
Chromosomes, Human, Pair 1
3
2023
95
0.350
Why?
Polycomb Repressive Complex 2
2
2021
47
0.350
Why?
Stem Cell Transplantation
3
2022
188
0.340
Why?
Epigenesis, Genetic
4
2020
396
0.340
Why?
Evolution, Molecular
2
2021
98
0.330
Why?
Tretinoin
1
2010
53
0.320
Why?
Treatment Outcome
10
2025
5508
0.310
Why?
Risk Assessment
4
2024
1349
0.300
Why?
Transcription Factors
3
2023
570
0.300
Why?
Transcriptome
3
2025
357
0.300
Why?
Immunoglobulin kappa-Chains
2
2021
22
0.300
Why?
Disease Progression
8
2025
870
0.290
Why?
DNA-Binding Proteins
2
2021
423
0.280
Why?
Neoplasm Proteins
3
2020
328
0.270
Why?
Melanoma
1
2010
272
0.260
Why?
Pyrimidines
2
2026
199
0.260
Why?
Retrospective Studies
8
2025
6694
0.250
Why?
RANK Ligand
2
2024
188
0.250
Why?
Pyrimethamine
1
2026
1
0.250
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
90
0.240
Why?
Biopsy
2
2018
594
0.240
Why?
Skin Neoplasms
1
2010
496
0.230
Why?
Radiopharmaceuticals
3
2021
198
0.230
Why?
Chemokine CCL3
1
2024
12
0.220
Why?
HMGB1 Protein
1
2024
21
0.220
Why?
Dexamethasone
3
2024
434
0.220
Why?
T-Lymphocytes
5
2024
318
0.220
Why?
Kaplan-Meier Estimate
3
2021
485
0.220
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.220
Why?
Chemokine CXCL12
1
2024
35
0.220
Why?
Antigens, CD19
1
2024
27
0.210
Why?
Bone Resorption
2
2024
300
0.210
Why?
Mutation Rate
2
2021
36
0.210
Why?
Mice
7
2026
5899
0.200
Why?
Genome-Wide Association Study
1
2024
184
0.200
Why?
Myeloproliferative Disorders
1
2023
32
0.200
Why?
Sulfonamides
2
2026
137
0.200
Why?
Cell Cycle
2
2021
236
0.200
Why?
Neoplasm Staging
2
2024
768
0.200
Why?
Genomics
2
2023
266
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
75
0.190
Why?
Drug Approval
1
2022
39
0.190
Why?
Qualitative Research
1
2024
365
0.180
Why?
Osteolysis
1
2022
74
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
Osteocytes
1
2024
219
0.180
Why?
Lymphoma, B-Cell
1
2022
60
0.180
Why?
Polymorphism, Single Nucleotide
1
2024
506
0.180
Why?
Bone Marrow Transplantation
1
2022
110
0.180
Why?
Hematologic Diseases
1
2021
21
0.180
Why?
Patient Participation
1
2022
65
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Genetic Predisposition to Disease
1
2024
525
0.170
Why?
Chromosome Deletion
2
2023
138
0.170
Why?
Abnormal Karyotype
1
2021
6
0.170
Why?
Drug Design
2
2013
122
0.170
Why?
Myeloma Proteins
1
2021
26
0.170
Why?
Immunoglobulin A
1
2021
46
0.170
Why?
Risk Factors
8
2024
3971
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2022
230
0.170
Why?
Communicable Diseases
1
2021
55
0.170
Why?
Hematologic Neoplasms
1
2022
101
0.170
Why?
Animals
9
2026
13485
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.160
Why?
Salvage Therapy
1
2021
137
0.160
Why?
Immunoglobulin G
1
2021
193
0.160
Why?
Practice Guidelines as Topic
1
2023
498
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Bone Diseases
1
2021
91
0.160
Why?
Neoplasm Invasiveness
1
2021
278
0.160
Why?
Gene Amplification
1
2019
59
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.150
Why?
Atrial Fibrillation
1
2022
196
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
United States
3
2024
5215
0.150
Why?
Healthcare Disparities
1
2022
291
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.150
Why?
Comorbidity
1
2021
637
0.150
Why?
Models, Statistical
1
2020
230
0.150
Why?
Spleen
1
2019
166
0.140
Why?
Spinal Fractures
1
2018
38
0.140
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Bacteremia
1
2019
87
0.140
Why?
Adipocytes
1
2018
127
0.140
Why?
Cell Differentiation
3
2022
667
0.140
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Disease-Free Survival
4
2019
461
0.130
Why?
Kidney Function Tests
1
2017
56
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Glomerular Filtration Rate
1
2017
126
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Chromosome Aberrations
2
2023
295
0.130
Why?
Survival Rate
4
2020
944
0.130
Why?
Pelvis
1
2017
65
0.130
Why?
Histoplasma
1
2016
24
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
HIV Infections
1
2021
394
0.130
Why?
Receptor, TIE-2
1
2016
16
0.130
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.120
Why?
Histoplasmosis
1
2016
48
0.120
Why?
Urea
1
2016
80
0.120
Why?
Indazoles
1
2016
47
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.120
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
94
0.120
Why?
Remission Induction
3
2024
218
0.120
Why?
Gastrointestinal Diseases
1
2016
126
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
Apoptosis
3
2026
1120
0.120
Why?
Proteasome Inhibitors
1
2016
101
0.110
Why?
Immunologic Factors
1
2016
114
0.110
Why?
Cell Cycle Checkpoints
1
2015
32
0.110
Why?
Time Factors
2
2021
2987
0.110
Why?
Kidney Diseases
1
2017
230
0.110
Why?
Cluster Analysis
1
2015
236
0.110
Why?
Xenograft Model Antitumor Assays
1
2015
218
0.110
Why?
Thrombopoiesis
1
2014
5
0.110
Why?
Neoplastic Stem Cells
1
2015
88
0.110
Why?
Hydrazines
1
2014
19
0.110
Why?
Myocardium
1
2017
471
0.110
Why?
Benzoates
1
2014
22
0.110
Why?
Immunotherapy
1
2016
251
0.110
Why?
Cystatin M
2
2024
17
0.100
Why?
Disease Models, Animal
2
2016
1483
0.100
Why?
Cell Survival
1
2015
598
0.100
Why?
Cross-Sectional Studies
3
2023
1677
0.100
Why?
Pyrazoles
1
2014
116
0.100
Why?
Chromosomes, Human, Pair 7
1
2012
29
0.090
Why?
Clone Cells
2
2023
76
0.090
Why?
Cardiovascular Diseases
1
2017
493
0.090
Why?
Flow Cytometry
2
2012
396
0.090
Why?
STAT3 Transcription Factor
1
2012
89
0.090
Why?
Chromatin
2
2024
143
0.090
Why?
Thalidomide
1
2014
376
0.090
Why?
Cell Transformation, Neoplastic
1
2013
187
0.090
Why?
Follow-Up Studies
3
2024
2294
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
262
0.080
Why?
Leukemia, Promyelocytic, Acute
1
2010
11
0.080
Why?
Luciferases
1
2010
50
0.080
Why?
Response Elements
1
2010
29
0.080
Why?
Gene Silencing
1
2010
122
0.080
Why?
Alleles
2
2021
279
0.080
Why?
Tumor Burden
2
2020
132
0.080
Why?
Recombinant Fusion Proteins
1
2010
177
0.080
Why?
Transfection
1
2010
365
0.080
Why?
Molecular Structure
1
2010
317
0.080
Why?
Histones
2
2021
315
0.070
Why?
DNA Copy Number Variations
2
2021
116
0.070
Why?
Syndecan-1
2
2021
73
0.070
Why?
Case-Control Studies
2
2024
1202
0.060
Why?
Tumor Cells, Cultured
2
2020
441
0.060
Why?
Imaging, Three-Dimensional
2
2017
150
0.060
Why?
Gene Expression Regulation
1
2010
1004
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
ROC Curve
1
2025
249
0.060
Why?
Arkansas
2
2021
2013
0.050
Why?
Telomere
1
2024
39
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
34
0.050
Why?
Killer Cells, Natural
1
2024
111
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
140
0.050
Why?
Antibodies
1
2024
144
0.050
Why?
B-Lymphocytes
1
2024
178
0.050
Why?
Demography
1
2023
92
0.050
Why?
Receptors, Antigen, T-Cell
1
2023
48
0.050
Why?
Cell Communication
1
2023
74
0.050
Why?
Neoplasms
1
2013
1314
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
50
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
United States Food and Drug Administration
1
2022
89
0.050
Why?
Patient Selection
1
2023
269
0.050
Why?
Oncogenes
1
2021
61
0.040
Why?
Infant
1
2010
3709
0.040
Why?
Phylogeny
1
2022
229
0.040
Why?
Tomography, X-Ray Computed
2
2017
1140
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Transcriptional Activation
1
2021
127
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
108
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
19
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
62
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
56
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
Protein Kinase Inhibitors
1
2022
231
0.040
Why?
Osteoclasts
1
2022
423
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Genetic Variation
1
2020
226
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
178
0.040
Why?
Health Status Disparities
1
2022
218
0.040
Why?
Multivariate Analysis
1
2021
601
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
29
0.040
Why?
Syndrome
1
2019
247
0.040
Why?
Pseudomonas Infections
1
2019
55
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
625
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.030
Why?
Protein-Tyrosine Kinases
1
2018
92
0.030
Why?
False Positive Reactions
1
2017
64
0.030
Why?
Bone and Bones
1
2021
492
0.030
Why?
Amino Acid Sequence
1
2018
576
0.030
Why?
Itraconazole
1
2016
37
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Databases, Factual
1
2020
721
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Amphotericin B
1
2016
104
0.030
Why?
Genes, p53
1
2016
50
0.030
Why?
Intestinal Obstruction
1
2016
36
0.030
Why?
Ileum
1
2016
87
0.030
Why?
NF-kappa B
1
2018
326
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
Colonoscopy
1
2016
105
0.030
Why?
Gene Knockdown Techniques
1
2016
110
0.030
Why?
Staphylococcal Infections
1
2019
270
0.030
Why?
Models, Genetic
1
2016
173
0.030
Why?
Genomic Instability
1
2016
87
0.030
Why?
Fever
1
2016
112
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
135
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
96
0.030
Why?
Logistic Models
1
2018
930
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
147
0.030
Why?
Heart
1
2017
352
0.030
Why?
Proportional Hazards Models
1
2016
446
0.030
Why?
Algorithms
1
2018
673
0.030
Why?
Echocardiography
1
2017
409
0.030
Why?
Weight Loss
1
2016
257
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Young Adult
1
2024
4346
0.030
Why?
Antifungal Agents
1
2016
347
0.030
Why?
Longitudinal Studies
1
2016
756
0.030
Why?
Models, Immunological
1
2013
8
0.030
Why?
Chemistry, Pharmaceutical
1
2013
35
0.020
Why?
Early Diagnosis
1
2013
84
0.020
Why?
Karyotyping
1
2012
77
0.020
Why?
Azacitidine
1
2012
39
0.020
Why?
Primary Cell Culture
1
2012
63
0.020
Why?
Cell Lineage
1
2012
92
0.020
Why?
Polymerase Chain Reaction
1
2013
458
0.020
Why?
Child
1
2024
7194
0.020
Why?
Antigens, CD
1
2012
213
0.020
Why?
Enzyme Inhibitors
1
2013
378
0.020
Why?
Magnetic Resonance Imaging
1
2017
1507
0.020
Why?
Cytokines
1
2013
622
0.020
Why?
Reproducibility of Results
1
2013
1223
0.020
Why?
Cohort Studies
1
2013
1576
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description